Gilead Sciences to Acquire Ouro Medicines
26 Mar 2026 //
BUSINESSWIRE
FDA Fast-Tracks Ouro`s Gamgertamig for ITP, AIHA
20 Jan 2026 //
PR NEWSWIRE
Ouro Medicines Granted FDA Orphan Drug Status For Gamgertamig
08 Dec 2025 //
PR NEWSWIRE
Ouro Medicines to Trial OM336 for Autoimmune Cytopenias
12 Jun 2025 //
PR NEWSWIRE

Market Place
Sourcing Support